Site Head, Surrey Memorial Hospital, Program of Laboratory Medicine and Pathology, Fraser Health Authority and Clinical Associate Professor in the Department of Pathology and Laboratory Medicine, University of British Columbia.
Dr Krikler is a Board Member of the Canadian Hemochromatosis Society.
- FASCP. 1995
- FRCPC (Hematopathology). 1985
- MBChB, Medicine, University of Rhodesia. 1975-1979
- LRCP (Edinburgh), MRCS (Edinburgh), LRCP&S (Glasgow). 1979
- Cruz E, Whittington C, Krikler SH, Mascarenhas C, Lacerda R, Vieira J, Porto G. A new 500 kb haplotype associated with high CD8+ T-lymphocyte numbers predicts a less severe expression of hereditary hemochromatosis. BMC Med Genet. 2008 Nov 6;9:97.
- Krikler SH, Heathcote JC. Prevalence of Iron Overload in the Lower Mainland of BC. BC Med J. 2002; 44(2):80-82.
- Chow EY, Haley LP, Krikler SH, Wadsworth LD. Hb Seattle [beta 70(E14)Ala- > Asp]: a report of a second kindred in a Ukrainian family. Hemoglobin. 1994 May;18(3):231-4.
- Pi DW, Krikler SH, Sparling TG, Carter CJ, Wadsworth LD. Reappraisal of optimal hemoglobin standards for female blood donors in Canada. Transfusion. 1994 Jan;34(1):7-10.
- Hull RD, Raskob GE, Pineo GF, et al. Subcutaneous low molecular weight heparin compared with continuous intravenous heparin in the treatment of proximal vein thrombosis. New Engl J Med 326:975-982; 1992.
- Hereditary Hemochromatosis
Teaching of interns, residents and laboratory technologists.